Application 010418
- Type
- NDA
- Sponsor
- ASTRAZENECA
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 005 | XYLOCAINE | LIDOCAINE HYDROCHLORIDE | INJECTABLE;INJECTION | 1% | No | No |
| 006 | XYLOCAINE W/ EPINEPHRINE | EPINEPHRINE; LIDOCAINE HYDROCHLORIDE | INJECTABLE;INJECTION | 0.005MG/ML;1% | No | No |
| 007 | XYLOCAINE | LIDOCAINE HYDROCHLORIDE | INJECTABLE;INJECTION | 2% | No | No |
| 008 | XYLOCAINE W/ EPINEPHRINE | EPINEPHRINE; LIDOCAINE HYDROCHLORIDE | INJECTABLE;INJECTION | 0.005MG/ML;2% | No | No |
| 009 | XYLOCAINE | LIDOCAINE HYDROCHLORIDE | INJECTABLE;INJECTION | 1.5% | No | No |
| 010 | XYLOCAINE W/ EPINEPHRINE | EPINEPHRINE; LIDOCAINE HYDROCHLORIDE | INJECTABLE;INJECTION | 0.005MG/ML;1.5% | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N010418-005 | XYLOCAINE | LIDOCAINE HYDROCHLORIDE | 1% | INJECTABLE / INJECTION | Approved before 1982 | ||
| N010418-006 | XYLOCAINE W/ EPINEPHRINE | EPINEPHRINE; LIDOCAINE HYDROCHLORIDE | 0.005MG/ML;1% | INJECTABLE / INJECTION | Approved before 1982 | ||
| N010418-007 | XYLOCAINE | LIDOCAINE HYDROCHLORIDE | 2% | INJECTABLE / INJECTION | Approved before 1982 | ||
| N010418-008 | XYLOCAINE W/ EPINEPHRINE | EPINEPHRINE; LIDOCAINE HYDROCHLORIDE | 0.005MG/ML;2% | INJECTABLE / INJECTION | Approved before 1982 | ||
| N010418-009 | XYLOCAINE | LIDOCAINE HYDROCHLORIDE | 1.5% | INJECTABLE / INJECTION | Approved before 1982 | ||
| N010418-010 | XYLOCAINE W/ EPINEPHRINE | EPINEPHRINE; LIDOCAINE HYDROCHLORIDE | 0.005MG/ML;1.5% | INJECTABLE / INJECTION | Approved before 1982 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | N010418-005 | XYLOCAINE | 1% | INJECTABLE / INJECTION | Approved before 1982 | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | N010418-006 | XYLOCAINE W/ EPINEPHRINE | 0.005MG/ML;1% | INJECTABLE / INJECTION | Approved before 1982 | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | N010418-007 | XYLOCAINE | 2% | INJECTABLE / INJECTION | Approved before 1982 | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | N010418-008 | XYLOCAINE W/ EPINEPHRINE | 0.005MG/ML;2% | INJECTABLE / INJECTION | Approved before 1982 | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | N010418-009 | XYLOCAINE | 1.5% | INJECTABLE / INJECTION | Approved before 1982 | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | N010418-010 | XYLOCAINE W/ EPINEPHRINE | 0.005MG/ML;1.5% | INJECTABLE / INJECTION | Approved before 1982 | 84e616aacf4f… | ||
| 2026-08-18 06:07:40 | 2026-07 | N010418-005 | XYLOCAINE | 1% | INJECTABLE / INJECTION | Approved before 1982 | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | N010418-006 | XYLOCAINE W/ EPINEPHRINE | 0.005MG/ML;1% | INJECTABLE / INJECTION | Approved before 1982 | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | N010418-007 | XYLOCAINE | 2% | INJECTABLE / INJECTION | Approved before 1982 | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | N010418-008 | XYLOCAINE W/ EPINEPHRINE | 0.005MG/ML;2% | INJECTABLE / INJECTION | Approved before 1982 | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | N010418-009 | XYLOCAINE | 1.5% | INJECTABLE / INJECTION | Approved before 1982 | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | N010418-010 | XYLOCAINE W/ EPINEPHRINE | 0.005MG/ML;1.5% | INJECTABLE / INJECTION | Approved before 1982 | caaa826d4ba7… | ||
| 2026-02-19 14:30 UTC | 2026-02 | N010418-005 | XYLOCAINE | 1% | INJECTABLE / INJECTION | Approved before 1982 | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | N010418-006 | XYLOCAINE W/ EPINEPHRINE | 0.005MG/ML;1% | INJECTABLE / INJECTION | Approved before 1982 | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | N010418-007 | XYLOCAINE | 2% | INJECTABLE / INJECTION | Approved before 1982 | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | N010418-008 | XYLOCAINE W/ EPINEPHRINE | 0.005MG/ML;2% | INJECTABLE / INJECTION | Approved before 1982 | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | N010418-009 | XYLOCAINE | 1.5% | INJECTABLE / INJECTION | Approved before 1982 | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | N010418-010 | XYLOCAINE W/ EPINEPHRINE | 0.005MG/ML;1.5% | INJECTABLE / INJECTION | Approved before 1982 | 011fe1cb6892… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N010418-005 | XYLOCAINE | 1% | INJECTABLE / INJECTION | Approved before 1982 | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N010418-006 | XYLOCAINE W/ EPINEPHRINE | 0.005MG/ML;1% | INJECTABLE / INJECTION | Approved before 1982 | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N010418-007 | XYLOCAINE | 2% | INJECTABLE / INJECTION | Approved before 1982 | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N010418-008 | XYLOCAINE W/ EPINEPHRINE | 0.005MG/ML;2% | INJECTABLE / INJECTION | Approved before 1982 | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N010418-009 | XYLOCAINE | 1.5% | INJECTABLE / INJECTION | Approved before 1982 | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N010418-010 | XYLOCAINE W/ EPINEPHRINE | 0.005MG/ML;1.5% | INJECTABLE / INJECTION | Approved before 1982 | 31067a03dcf5… | ||
| 2025-08-23 18:47 UTC | 2025-08 | N010418-005 | XYLOCAINE | 1% | INJECTABLE / INJECTION | Approved before 1982 | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | N010418-006 | XYLOCAINE W/ EPINEPHRINE | 0.005MG/ML;1% | INJECTABLE / INJECTION | Approved before 1982 | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | N010418-007 | XYLOCAINE | 2% | INJECTABLE / INJECTION | Approved before 1982 | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | N010418-008 | XYLOCAINE W/ EPINEPHRINE | 0.005MG/ML;2% | INJECTABLE / INJECTION | Approved before 1982 | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | N010418-009 | XYLOCAINE | 1.5% | INJECTABLE / INJECTION | Approved before 1982 | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | N010418-010 | XYLOCAINE W/ EPINEPHRINE | 0.005MG/ML;1.5% | INJECTABLE / INJECTION | Approved before 1982 | 6a471c1ec25d… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N010418-005 | XYLOCAINE | 1% | INJECTABLE / INJECTION | Approved before 1982 | fd3edfee7708… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N010418-006 | XYLOCAINE W/ EPINEPHRINE | 0.005MG/ML;1% | INJECTABLE / INJECTION | Approved before 1982 | fd3edfee7708… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N010418-007 | XYLOCAINE | 2% | INJECTABLE / INJECTION | Approved before 1982 | fd3edfee7708… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N010418-008 | XYLOCAINE W/ EPINEPHRINE | 0.005MG/ML;2% | INJECTABLE / INJECTION | Approved before 1982 | fd3edfee7708… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N010418-009 | XYLOCAINE | 1.5% | INJECTABLE / INJECTION | Approved before 1982 | fd3edfee7708… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N010418-010 | XYLOCAINE W/ EPINEPHRINE | 0.005MG/ML;1.5% | INJECTABLE / INJECTION | Approved before 1982 | fd3edfee7708… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N010418-005 | XYLOCAINE | 1% | INJECTABLE / INJECTION | Approved before 1982 | b8a1b40f171c… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N010418-006 | XYLOCAINE W/ EPINEPHRINE | 0.005MG/ML;1% | INJECTABLE / INJECTION | Approved before 1982 | b8a1b40f171c… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N010418-007 | XYLOCAINE | 2% | INJECTABLE / INJECTION | Approved before 1982 | b8a1b40f171c… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N010418-008 | XYLOCAINE W/ EPINEPHRINE | 0.005MG/ML;2% | INJECTABLE / INJECTION | Approved before 1982 | b8a1b40f171c… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Lidocaine hydrochloride | LIDOCAINE HYDROCHLORIDE | Atlantic Biologicals Corp. | 401ecb6c-392b-1d74-e063-6294a90a4005 | 2025-10-01 | Boxed warning, Warnings, Adverse reactions | LIDOCAINE HYDROCHLORIDE |
| LIDOCAINE HYDROCHLORIDE | LIDOCAINE HYDROCHLORIDE | Henry Schein, Inc. | ee21518e-b3ed-405a-ac3b-bfe753893dba | 2025-09-29 | Warnings, Adverse reactions | LIDOCAINE HYDROCHLORIDE |
| Medi-First Burn | LIDOCAINE HYDROCHLORIDE | Unifirst First Aid Corporation | 44bb5f25-1114-4bb1-8bcf-40402594abc4 | 2025-09-09 | Warnings | LIDOCAINE HYDROCHLORIDE |
| MediFirst Burn | LIDOCAINE HYDROCHLORIDE | Unifirst First Aid Corporation | 9fa5b348-29c2-4cd0-a945-0486bd27f5e0 | 2025-09-08 | Warnings | LIDOCAINE HYDROCHLORIDE |
| Lidocaine Hydrochloride | LIDOCAINE HYDROCHLORIDE | Unifirst First Aid Corporation | 4c2e2b91-d2f6-4e41-9a4c-ecabca9830e8 | 2025-09-08 | Warnings | LIDOCAINE HYDROCHLORIDE |
| HealthWise 4% Lidocaine Cream 2.7 oz | LIDOCAINE HYDROCHLORIDE | Veridian Healthcare | f39eb3d0-e153-4f50-85b1-ad5c677d176c | 2025-08-28 | Warnings | LIDOCAINE HYDROCHLORIDE |
| Lidocaine Hydrochloride | LIDOCAINE HYDROCHLORIDE | Cintas First Aid & Safety | 96f17095-31f3-4b8a-ab22-0caaefaa7476 | 2025-08-15 | Warnings | LIDOCAINE HYDROCHLORIDE |
| Aruba Aloe Alcoholada | LIDOCAINE HYDROCHLORIDE | Aruba Aloe Balm NV | f56c62b0-75db-4499-858e-54e10b0e140a | 2025-08-07 | Warnings | LIDOCAINE HYDROCHLORIDE |
| Lidocaine Hydrochloride | LIDOCAINE HYDROCHLORIDE | Lannett Company, Inc. | c3353e08-2a8c-4ace-ba89-114f7131b8de | 2025-08-07 | Warnings, Adverse reactions | LIDOCAINE HYDROCHLORIDE |
| Xylocaine | LIDOCAINE HYDROCHLORIDE, EPINEPHRINE BITARTRATE INJECTION, SOLUTION | Henry Schein, Inc | 9e8d0318-b2fe-4084-aedf-de97f61605a8 | 2025-08-07 | Warnings, Adverse reactions | Xylocaine |
| LIDOCAINE HYDROCHLORIDE | LIDOCAINE HYDROCHLORIDE | Aurobindo Pharma Limited | ab461805-413a-4fb3-88a1-224e1c423084 | 2025-07-30 | Boxed warning, Warnings, Adverse reactions | LIDOCAINE HYDROCHLORIDE |
| Xylocaine | LIDOCAINE HYDROCHLORIDE,EPINEPHRINE BITARTRATE | ProPharma Distribution | 386c23fd-1691-98b2-e063-6294a90ab070 | 2025-07-18 | Warnings, Adverse reactions | Xylocaine |
| QUALITY CHOICE Maximum Strength Lidocaine Pain Relief Roll On | LIDOCAINE HYDROCHLORIDE | CHAIN DRUG MARKETING ASSOCIATION | 7b3ff4c1-0b60-4f7a-8aa4-c84b7c7137c4 | 2025-07-11 | Warnings | LIDOCAINE HYDROCHLORIDE |
| Lidocaine Hydrochloride | LIDOCAINE HYDROCHLORIDE | Sun Pharmaceutical Industries, Inc. | 845b96c1-36a3-431f-8316-112ae881d934 | 2025-07-07 | Warnings, Adverse reactions | LIDOCAINE HYDROCHLORIDE |
| LIDOCAINE HYDROCHLORIDE | LIDOCAINE HYDROCHLORIDE | Henry Schein, Inc. | 767374af-89d1-4c19-bd8e-480699b45cf7 | 2025-06-11 | Warnings, Adverse reactions | LIDOCAINE HYDROCHLORIDE |
| Burn | LIDOCAINE HYDROCHLORIDE | J&A Digital Inc. | d4b09055-b93e-466f-9e24-cae098af6e24 | 2025-06-02 | Warnings | LIDOCAINE HYDROCHLORIDE |
| Xylocaine | LIDOCAINE HYDROCHLORIDE | Asclemed USA, Inc. | 25370b0f-0ac6-4a03-abe6-d73d65192180 | 2025-05-31 | Warnings, Adverse reactions | Xylocaine LIDOCAINE HYDROCHLORIDE |
| Lidocaine hydrochloride | LIDOCAINE HYDROCHLORIDE | ATLANTIC BIOLOGICALS CORP. | 75d17334-6876-42d0-8a02-82669d139e4f | 2025-05-12 | Boxed warning, Warnings, Adverse reactions | LIDOCAINE HYDROCHLORIDE |
| Lidocaine Hydrochloride | LIDOCAINE HYDROCHLORIDE | Huons Co., Ltd. | 8ec2d256-fc4f-44f6-bee2-eef2bf3bf580 | 2025-05-09 | Warnings, Adverse reactions | LIDOCAINE HYDROCHLORIDE |
| Lidocaine | LIDOCAINE HYDROCHLORIDE | Hikma Pharmaceuticals USA Inc. | 5523fdfe-69fd-49a5-b51f-73e2223d49a9 | 2025-05-01 | Warnings, Adverse reactions | LIDOCAINE HYDROCHLORIDE |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.